Korea Investment Corp’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.64M | Sell |
36,889
-50,100
| -58% | -$6.3M | 0.01% | 615 |
|
|
2025
Q1 | $9.62M | Buy |
86,989
+25,900
| +42% | +$2.86M | 0.02% | 515 |
|
|
2024
Q4 | $8.34M | Sell |
61,089
-5,100
| -8% | -$696K | 0.02% | 555 |
|
|
2024
Q3 | $7.63M | Sell |
66,189
-41,288
| -38% | -$4.76M | 0.02% | 523 |
|
|
2024
Q2 | $14.8M | Buy |
107,477
+69,372
| +182% | +$9.55M | 0.04% | 387 |
|
|
2024
Q1 | $5.26M | Sell |
38,105
-45,324
| -54% | -$6.25M | 0.01% | 569 |
|
|
2023
Q4 | $11M | Buy |
83,429
+48,280
| +137% | +$6.36M | 0.03% | 443 |
|
|
2023
Q3 | $3.95M | Buy |
35,149
+19,768
| +129% | +$2.22M | 0.01% | 546 |
|
|
2023
Q2 | $1.45M | Sell |
15,381
-1,165
| -7% | -$110K | ﹤0.01% | 692 |
|
|
2023
Q1 | $1.67M | Sell |
16,546
-1,879
| -10% | -$190K | ﹤0.01% | 687 |
|
|
2022
Q4 | $2.2M | Buy |
18,425
+3,186
| +21% | +$381K | 0.01% | 679 |
|
|
2022
Q3 | $1.62M | Buy |
15,239
+8,099
| +113% | +$860K | 0.01% | 692 |
|
|
2022
Q2 | $696K | Buy |
+7,140
| New | +$696K | ﹤0.01% | 727 |
|
|
2021
Q3 | – | Sell |
-2,200
| Closed | -$214K | – | 743 |
|
|
2021
Q2 | $214K | Sell |
2,200
-200
| -8% | -$19.5K | ﹤0.01% | 737 |
|
|
2021
Q1 | $233K | Sell |
2,400
-23,500
| -91% | -$2.28M | ﹤0.01% | 710 |
|
|
2020
Q4 | $2.48M | Buy |
25,900
+1,600
| +7% | +$153K | 0.01% | 633 |
|
|
2020
Q3 | $2.34M | Buy |
24,300
+1,000
| +4% | +$96.2K | 0.01% | 574 |
|
|
2020
Q2 | $2.84M | Buy |
23,300
+1,400
| +6% | +$171K | 0.01% | 537 |
|
|
2020
Q1 | $1.9M | Buy |
+21,900
| New | +$1.9M | 0.01% | 574 |
|